BTCG 1808
Research payments
$2,218,653
Through program year 2019, $2,218,653 in research payments was reported against BTCG 1808, across 154 payments, paid by Taro Pharmaceuticals USA, Inc..
- Paid by
- Taro Pharmaceuticals USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $2,218,653 | 154 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Francisco Flores Miramar, FL Named on 31 payments
- Hector Wiltz Jr Miami, FL Named on 13 payments
- Aldo Maspons El Paso, TX Named on 13 payments
- Manuel Sanchez Miami Lakes, FL Named on 11 payments
- Bruce Torkan Los Angeles, CA Named on 10 payments
- Scott Miller Charleston, WV Named on 10 payments
- James Moretti Pittsburgh, PA Named on 9 payments
- Gerard Acloque Miami, FL Named on 8 payments
- Yamirka Duardo-Guerra Miami, FL Named on 8 payments
- Shahram Jacobs Encino, CA Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.